borderline significantp = 0.06
Between 2012 and 2019, a significant increase in the prevalence of eczema symptoms was observed (from 3.6% to 7.0%; p < 0.001), while asthma showed a borderline significant increase (p = 0.06) and rhinitis remained stable [ 79 ].